•
Mar 31, 2023

Elevance Health Q1 2023 Earnings Report

Elevance Health reported strong financial performance in Q1 2023, marked by double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Key Takeaways

Elevance Health reported a strong start to 2023, with a 10.6% year-over-year increase in operating revenue to $41.9 billion and a 16.6% increase in operating gain to $2.8 billion. Adjusted net income was $9.46 per share, and medical enrollment reached 48.1 million members.

GAAP net income was $8.30 per share, including net negative adjustment items of $1.16 per share.

Adjusted net income was $9.46 per share.

Operating revenue grew 10.6% year-over-year to $41.9 billion.

Medical enrollment increased to 48.1 million members.

Total Revenue
$41.9B
Previous year: $37.9B
+10.6%
EPS
$9.46
Previous year: $8.25
+14.7%
Total Medical Membership
48.1M
Previous year: 46.78M
+2.8%
Gross Profit
$38.7B
Previous year: $9.88B
+291.6%
Cash and Equivalents
$10.1B
Previous year: $6.16B
+64.6%
Free Cash Flow
$6.17B
Previous year: $2.29B
+169.7%
Total Assets
$109B
Previous year: $100B
+8.5%

Elevance Health

Elevance Health

Forward Guidance

Elevance Health expects GAAP net income to be greater than $29.50 per share in 2023, and adjusted net income to be greater than $32.70 per share.